Try our Advanced Search for more refined results
State of Washington et al v. United States Food and Drug Administration et al
Case Number:
1:23-cv-03026
Court:
Nature of Suit:
Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision
Judge:
Firms
Companies
- American Academy of Family Physicians
- American Academy of Pediatrics
- American College of Nurse-Midwives
- American Medical Association Inc.
- Washington State Medical Association
Government Agencies
- Food and Drug Administration
- State of Maryland
- State of Nevada
- U.S. Department of Health and Human Services
Sectors & Industries:
-
March 13, 2024
9th Circ. Unsure If Abortion Pill Suit Harms Red States
Two Ninth Circuit judges on Wednesday challenged Idaho and other Republican-led states' bid to intervene in Washington's lawsuit seeking to expand access to the abortion pill mifepristone, asking if the states could back up their claims of economic harm.
-
June 22, 2023
Abortion Litigation To Watch As Dobbs Decision Turns 1
The U.S. Supreme Court's elimination of the constitutional right to abortion hit like an earthquake last summer, uprooting long-standing reproductive rights, triggering state laws curbing abortion access and flooding courts with litigation. A year later, legal battles promise further shake-ups to the abortion landscape.
-
April 24, 2023
Red States Can't Join Washington's Abortion Pill Suit
A Washington federal judge has rejected a bid by Idaho and six other Republican-leaning states to join Washington's lawsuit challenging federal restrictions on the abortion pill mifepristone, ruling the case won't impair those states' ability to enforce their own state laws regulating medication abortion.
-
April 14, 2023
Feds, Wash. Fight Red States' Bid To Join Abortion Pill Suit
The U.S. Food and Drug Administration joined states led by Washington to urge a federal judge not to allow Idaho and a handful of Republican-led states to join a lawsuit challenging federal restrictions on the abortion pill mifepristone.
-
April 10, 2023
DOJ Asks 5th Circ. To End 'Misguided' Abortion Pill Order
The U.S. Department of Justice told the Fifth Circuit on Monday that the anti-abortion groups and physicians who sued to undo the U.S. Food and Drug Administration's 23-year-old approval of the abortion pill mifepristone lack standing and urged the court to halt a Texas federal judge's order blocking medication abortion access nationwide starting Friday.
-
April 10, 2023
Pharma Execs Slam Abortion Pill Ruling, Citing Industry Risk
Chief executive officers and top legal counsel for pharmaceutical and biotech companies, including Pfizer, said a Texas federal judge's Friday order blocking the effective date of the U.S. Food and Drug Administration's decades-old approval of the abortion drug mifepristone fundamentally undermines the agency's authority and threatens industry.
-
April 07, 2023
Texas Judge Pushes Pause On FDA Abortion Drug Approval
A Texas federal judge Friday blocked the effective date of the U.S. Food and Drug Administration's decades-old approval of the abortion drug mifepristone and gave the Biden administration one week to appeal, drawing out a watershed ruling that could dramatically restrict abortion access in the U.S., where medication abortion has become the most common method to terminate pregnancies.
-
March 20, 2023
FDA Urges Court To Keep Abortion Drug Regulations Intact
The U.S. Food and Drug Administration told a Washington federal court that Democratic state attorneys general waited for more than two decades to challenge restrictions on abortion medication mifepristone, which in fact the agency has just loosened.
-
February 24, 2023
A Dozen Dem AGs Sue Over FDA's Abortion Drug Regulations
The attorneys general in a dozen states have asked a federal judge on Friday to rescind some of the U.S. Food and Drug Administration's regulations covering the abortion medication mifepristone, which they say have created new "Orwellian dangers" in the post-Dobbs legal climate.